DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue S 1 · Volume 30 · February 2004 DOI: 10.1055/s-002-3229 Expanded Role of Low-Molecular-Weight Heparins in Hematology and Oncology Editor in Chief Eberhard F Mammen M.D., Guest Editors Debra Hoppensteadt Ph.D. Rodger L Bick M.D. Ph.D. Jawed Fareed Ph.D.

PREFACE

  • 1
  • 3
  • 11
  • 25
  • 31
    Sutor, Anton Heinz; Chan, Anthony K. C.; Massicotte, Patricia:

    Low-Molecular-Weight Heparin in Pediatric Patients

  • 41
  • 49
    Hoppensteadt, Debra A.; Willows, Louise; Leitz, Helen; Nicolaides, Andrew; Fareed, Jawed:

    Laboratory Analysis of Blood Samples from Patients Treated with Tinzaparin

  • 57
    Walenga, Jeanine M.; Jeske, Walter P.; Prechel, M. Margaret; Bakhos, Mamdouh:

    Newer Insights on the Mechanism of Heparin-Induced Thrombocytopenia

  • 69
    Walenga, Jeanine M.; Jeske, Walter P.; Prechel, M. Margaret; Bacher, Peter; Bakhos, Mamdouh:

    Decreased Prevalence of Heparin-Induced Thrombocytopenia with Low-Molecular-Weight Heparin and Related Drugs

  • 81
    Messmore, Harry L.; Wehrmacher, William H.; Coyne, Erwin; Fareed, Jawed:

    Heparin to Pentasaccharide and Beyond: The End Is Not in Sight

  • 89
    Fareed, Jawed; Ma, Qing; Florian, Michelle; Maddineni, Jyothi; Iqbal, Omer; Hoppensteadt, Debra A.; Bick, Rodger L.:

    Differentiation of Low-Molecular-Weight Heparins: Impact on the Future of the Management of Thrombosis

  • 105
    Hoppensteadt, Debra A.; Fareed, Jawed; Bick, Rodger L.:

    Epilogue